Evaluation of Specific Cellular and Humoral Immune Response to <i>Toxoplasma gondii</i> in Patients with Autoimmune Rheumatic Diseases Immunomodulated Due to the Use of TNF Blockers

Evaluation of Specific Cellular and Humoral Immune Response to <i>Toxoplasma gondii</i> in Patients with Autoimmune Rheumatic Diseases Immunomodulated Due to the Use of TNF Blockers

(1) Background: TNF antagonists have been used to treat autoimmune diseases (AD). However, during the chronic phase of toxoplasmosis, TNF-α and TNFR play a significant role in maintaining disease resistance and latency. Several studies have demonstrated the risk of latent infections’ reactivation in...

Full description

Bibliographic Details
Main Authors: Cristhianne Molinero Ratkevicius Andrade, Aline Caroline de Lima Marques, Rodolfo Pessato Timóteo, Ana Carolina de Morais Oliveira-Scussel, Fernanda Bernadelli De Vito, Marcos Vinícius da Silva, José Roberto Mineo, Reginaldo Botelho Teodoro, Denise Bertulucci Rocha Rodrigues, Virmondes Rodrigues Júnior
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Biomedicines
Subjects:
TNF-α blockers
immunoglobulins
<i>Toxoplasma gondii</i>
immunosuppression
toxoplasmosis
immune response
Online Access:https://www.mdpi.com/2227-9059/11/3/930

Internet

https://www.mdpi.com/2227-9059/11/3/930

Similar Items